Seeing Is Believing
Currently out of the existing stock ratings of Whit Mayo, 130 are a BUY (52.85%), 103 are a HOLD (41.87%), 13 are a SELL (5.28%).
Analyst Whit Mayo, currently employed at LEERINK, carries an average stock price target met ratio of 78.44% that have a potential upside of 21.46% achieved within 254 days.
Whit Mayo’s has documented 473 price targets and ratings displayed on 36 stocks. The coverage is on Healthcare, Financial Services sectors.
Most recent stock forecast was given on AIRS, Airsculpt Technologies at 31-Mar-2025.
Analyst best performing recommendations are on EHAB (ENHABIT).
The best stock recommendation documented was for CLOV (CLOVER HEALTH INVESTMENTS CORP) at 11/8/2022. The price target of $1.5 was fulfilled within 3 days with a profit of $0.21 (16.28%) receiving and performance score of 54.26.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$30
$2.85 (10.50%)
$26
4 days ago
(02-Oct-2025)
10/12 (83.33%)
$2.85 (10.50%)
503
Hold
$22
$-5.15 (-18.97%)
$32
1 months 23 days ago
(13-Aug-2025)
19/24 (79.17%)
$1.34 (6.49%)
76
Buy
$28
$0.85 (3.13%)
$43
1 months 24 days ago
(12-Aug-2025)
0/10 (0%)
$7.23 (34.81%)
Buy
$29
$1.85 (6.81%)
$36
2 months ago
(06-Aug-2025)
0/2 (0%)
$10.8 (59.34%)
Hold
$20
$-7.15 (-26.34%)
$28
2 months ago
(06-Aug-2025)
3/13 (23.08%)
$1.8 (9.89%)
204
What Year was the first public recommendation made by Whit Mayo?